Application of 149353-95-7, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 149353-95-7, Name is 2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-7-carboxylic acid, molecular formula is C15H19NO4. In a Article£¬once mentioned of 149353-95-7
RGD mimetics containing phthalimidine fragment as novel ligands of fibrinogen receptor
The novel RGD mimetics with phthalimidine central fragment were synthesized with the use of 4-piperidine-4-yl-butyric, 4-piperidine-4-yl-benzoic, 4-piperazine-4-yl-benzoic and 1,2,3,4-tetrahydroisoquinoline-7-carboxylic acids as surrogates of Arg motif. The synthesized compounds potently inhibited platelet aggregation in vitro and blocked FITC-Fg binding to alphaIIbbeta3 integrin in a suspension of washed human platelets. The key alphaIIbbeta3 protein-ligand interactions were determined in docking experiments.
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Application of 149353-95-7. In my other articles, you can also check out more blogs about 149353-95-7
Reference£º
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem